CN1073563C - 4,6－二叔丁基－2,3－二氢苯并噻吩衍生物 - Google Patents

4,6－二叔丁基－2,3－二氢苯并噻吩衍生物 Download PDF

Info

Publication number
CN1073563C
CN1073563C CN95193057A CN95193057A CN1073563C CN 1073563 C CN1073563 C CN 1073563C CN 95193057 A CN95193057 A CN 95193057A CN 95193057 A CN95193057 A CN 95193057A CN 1073563 C CN1073563 C CN 1073563C
Authority
CN
China
Prior art keywords
chain
straight chain
branched
group
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95193057A
Other languages
English (en)
Chinese (zh)
Other versions
CN1148386A (zh
Inventor
加藤好章
石川彰
田村邦雄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of CN1148386A publication Critical patent/CN1148386A/zh
Application granted granted Critical
Publication of CN1073563C publication Critical patent/CN1073563C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02—Monothiocarbamic acids; Derivatives thereof
    • C07C333/04—Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN95193057A 1994-04-11 1995-04-11 4,6－二叔丁基－2,3－二氢苯并噻吩衍生物 Expired - Fee Related CN1073563C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10736594 1994-04-11
JP107365/94 1994-04-11
JP107365/1994 1994-04-11

Publications (2)

Publication Number Publication Date
CN1148386A CN1148386A (zh) 1997-04-23
CN1073563C true CN1073563C (zh) 2001-10-24

Family

ID=14457243

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95193057A Expired - Fee Related CN1073563C (zh) 1994-04-11 1995-04-11 4,6－二叔丁基－2,3－二氢苯并噻吩衍生物

Country Status (8)

Country Link
US (1) US5789436A (enExample)
EP (1) EP0791589B1 (enExample)
CN (1) CN1073563C (enExample)
AT (1) ATE214059T1 (enExample)
AU (1) AU683552B2 (enExample)
DE (1) DE69525763T2 (enExample)
ES (1) ES2173182T3 (enExample)
WO (1) WO1995027710A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW565558B (en) * 1995-11-09 2003-12-11 Chugai Pharmaceutical Co Ltd Intimal thickening inhibitory agent
DE19548708A1 (de) * 1995-12-23 1997-06-26 Merck Patent Gmbh Cyclische Sulfone
KR100383835B1 (ko) * 1996-06-26 2003-08-27 쥬가이 세이야쿠 가부시키가이샤 신장질환치료제및장기보존제
CA2289676A1 (en) * 1997-05-08 1998-11-12 Chugai Seiyaku Kabushiki Kaisha Prophylactic/therapeutic agents for atherosclerosis
TW472051B (en) 1997-05-23 2002-01-11 Chugai Pharmaceutical Co Ltd 2,3-dihydrobenzofuran derivatives
CA2310847C (en) * 1997-11-28 2007-03-13 Knoll Aktiengesellschaft Method for producing solvent-free non-crystalline biologically active substances
AU3053199A (en) 1998-04-01 1999-10-25 Ono Pharmaceutical Co. Ltd. Fused thiophene derivatives and drugs containing the same as the active ingredient
DE10038709A1 (de) * 2000-08-09 2002-02-28 Aventis Pharma Gmbh Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen
CA2406913C (en) * 2001-02-22 2011-04-19 Teijin Limited Benzo[b]thiophene derivatives and processes for preparing the same
RU2184732C1 (ru) * 2001-04-26 2002-07-10 Некоммерческое партнерство "АСГЛ-Исследовательские лаборатории" 5,5-дизамещенные-2-метил-9,9-диоксо-9-тиабицикло[4.3.0]нонаны
WO2003082264A1 (en) * 2002-03-29 2003-10-09 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for preventing or treating respiratory disease
DE10260095A1 (de) * 2002-12-19 2004-07-01 Basell Polyolefine Gmbh Verfahren zur Herstellung von heterocyclischen Ketonen
CN102391521B (zh) * 2011-06-30 2013-08-21 北京林业大学 一种改性碱木质素及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS516958A (en) * 1974-06-06 1976-01-20 Labaz Benzo *b* chiofuenjudotainoseizoho
JPS60163877A (ja) * 1984-01-26 1985-08-26 フアイソンズ・ピーエルシー ベンゾピラン誘導体、それらを含有する組成物およびそれらの製法
JPH02121975A (ja) * 1988-10-28 1990-05-09 Eisai Co Ltd ２，３−ジヒドロベンゾフラン誘導体
EP0533579A1 (fr) * 1991-09-18 1993-03-24 Adir Et Compagnie Nouveaux dérivés de la trimétazidine, leur procédé de préparation et les compositions pharmaceutiques les contenant

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3530146A (en) * 1968-07-01 1970-09-22 American Cyanamid Co Substituted benzothiophendione compounds
JPS505356A (enExample) * 1973-05-30 1975-01-21
US4001426A (en) * 1974-10-17 1977-01-04 Smithkline Corporation Substituted benzofurans and benzothiophenes
US4224330A (en) * 1979-09-13 1980-09-23 Zoecon Corporation Esters and thiolesters of benzothienyl acids
JPS5646879A (en) * 1979-09-25 1981-04-28 Takeda Chem Ind Ltd Spiro compound, its preparation, and preventive and remedy for circulatory system disorder
US4436748A (en) * 1980-10-20 1984-03-13 Hoechst-Roussel Pharmaceuticals Inc. Benzo[b]thiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4521320A (en) * 1983-10-21 1985-06-04 Ciba Geigy Corporation Thiocarbamate stabilizers
EP0150966B1 (en) * 1984-01-26 1989-07-12 FISONS plc Benzopyran derivatives, compositions containing them and processes for their preparation
GB8406906D0 (en) * 1984-03-16 1984-04-18 Akzo Nv Benzo-thiazole and benzothiophene derivatives
GB8417559D0 (en) * 1984-07-10 1984-08-15 Pfizer Ltd Anti-diarrhoeal agents
US5112852A (en) * 1986-12-23 1992-05-12 Merrell Dow Pharmaceuticals Inc. Allenyl amines
DE58902111D1 (de) * 1988-03-16 1992-10-01 Ciba Geigy Ag Thioverbindungen.
GB2224028A (en) * 1988-10-18 1990-04-25 Merck & Co Inc Substituted 5-hydroxy-2,3-dihydrobenzothiophenes as inhibitors of leukotriene biosynthesis
US4963580A (en) * 1988-10-18 1990-10-16 Merck & Co., Inc. Substituted 5-hydroxy-2,3-dihydrobenzothiophenes as inhibitors of leukotriene biosynthesis
DE4115184A1 (de) * 1991-05-09 1992-11-12 Bayer Ag Benzothiophen-2-carboxamid-s,s-dioxide
DE4204969A1 (de) * 1992-02-19 1993-08-26 Basf Ag Verfahren zur herstellung von benzo(b)thiophenen
EP0639573A1 (de) * 1993-08-03 1995-02-22 Hoechst Aktiengesellschaft Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS516958A (en) * 1974-06-06 1976-01-20 Labaz Benzo *b* chiofuenjudotainoseizoho
JPS60163877A (ja) * 1984-01-26 1985-08-26 フアイソンズ・ピーエルシー ベンゾピラン誘導体、それらを含有する組成物およびそれらの製法
JPH02121975A (ja) * 1988-10-28 1990-05-09 Eisai Co Ltd ２，３−ジヒドロベンゾフラン誘導体
EP0533579A1 (fr) * 1991-09-18 1993-03-24 Adir Et Compagnie Nouveaux dérivés de la trimétazidine, leur procédé de préparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
AU2148595A (en) 1995-10-30
DE69525763D1 (de) 2002-04-11
EP0791589A1 (en) 1997-08-27
DE69525763T2 (de) 2002-10-02
ATE214059T1 (de) 2002-03-15
WO1995027710A1 (en) 1995-10-19
CN1148386A (zh) 1997-04-23
EP0791589A4 (enExample) 1997-08-27
ES2173182T3 (es) 2002-10-16
US5789436A (en) 1998-08-04
EP0791589B1 (en) 2002-03-06
AU683552B2 (en) 1997-11-13

Similar Documents

Publication Publication Date Title
CN1073563C (zh) 4,6－二叔丁基－2,3－二氢苯并噻吩衍生物
CN1173945C (zh) 5-硫代-ω-取代的苯基-前列腺素E衍生物、其制备方法及含有它们作为活性成分的药物
CN1108289C (zh) 二氟前列腺素衍生物及其使用
CN1906159A (zh) 前列腺素硝基氧衍生物
CN1027588C (zh) N-苯烷基取代的α-氨基羧基酰胺衍生物的制备方法
CN1193996C (zh) 可用作抗氧剂和5－脂氧合酶抑制剂及非甾体类抗炎药的抗炎非甾体类羧酸酯和酰胺
CN1243000C (zh) 生育酚、生育三烯酚、其它苯并二氢吡喃和侧链衍生物,及其用途
CN1012643B (zh) 环氧丙烷酮类化合物的制备方法
CN1354742A (zh) 人过氧化物酶体增殖剂活化受体(PPAR)a激动剂——取代苯基丙酸衍生物
HK1039615A1 (zh) 可用於治療脂血異常、動脉粥樣硬化和糖尿病的環狀化合物、藥物組合物和製備方法
CN1056680A (zh) 可用作人体白细胞弹性蛋白酶抑制剂的2-苯基链烷酸酯的制备方法
CN1032135C (zh) 具有粘液调节和抗局部缺血性质的2，3-二氢-5-氧-4，6，7-三甲基苯并呋喃的2-(rs)-衍生物的制备方法
CN1091636A (zh) 药物
CN1529702A (zh) 4-氨基苯并吡喃衍生物
CN1054980A (zh) 具有旋光活性的8-甲氧基喹诺酮羧酸衍生物，它们的制备方法以及它们的中间体
CN1074904A (zh) 苯并呋喃基-和噻吩基甲硫基-链烷羧酸衍生物
CN1121718A (zh) 杂环衍生物
CN1068817A (zh) 吲哚类衍生物
CN1038582C (zh) 对缺血性疾病有效的苯衍生物
CN1063443C (zh) 新的苯并噻唑衍生物
CN1594354A (zh) 齐墩果酸偶联衍生物及其药物用途
CN1283196A (zh) N－苯基酰胺和n－吡啶基酰胺、其制备方法和含有它们的药物组合物
CN1741985A (zh) 钙细胞溶解酶化合物
CN1025674C (zh) 取代的联苯
CN1538952A (zh) 用于合成埃坡霉素及其衍生物并经保护的3,5-二羟基-2,2-二甲基-戊酰胺及其制备方法和应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee